Risk Factors of Retinopathy of Prematurity in Premature Infants Weighing Less Than 1600 g

ABSTRACT

There are many risk factors contributing to retinopathy of prematurity (ROP). Some are still controversial, including the use of glucocorticoid and intraventricular hemorrhage. Hence, a retrospective study was performed to evaluate the association between the suspected risk factors and ROP in a medical center in southern Taiwan. One hundred fifty-nine infants with birth body weight < 1600 g admitted to our neonatal intensive care unit before the 29th day of life were enrolled into this study. Clinical data were analyzed by means of logistic regression. The prevalence of ROP in all infants (birthweight < 1600 g) is 36.48% (58 of 159) and 59.46% (22 of 37) in extremely low birthweight infants (birthweight ≤ 1000 g). One infant with gestational age 32 weeks and birthweight 1420 g developed stage III ROP. Logistic regression revealed six factors to be significant variables. Birthweight ≤ 1000 g, intraventricular hemorrhage, sepsis, and use of glucocorticoid or dopamine were risk factors associated with higher incidence of ROP. Supplementation of vitamin E was shown to relate to lower incidence of ROP. This study confirms several risk factors recognized in previous statistical analyses. Sepsis is the most significant factor contributing to ROP. Vitamin E was proven to be effective in prophylaxis of development of ROP. The possibility of development of ROP could not be excluded in infants with gestational age > 32 weeks.

KEYWORDS

Retinopathy of prematurity - extremely low birthweight - sepsis

REFERENCES

• 1 Bossi E, Koerner F. Retinopathy of prematurity.  Intensive Care Med. 1995;  21 241-246
• 2 Lucey J F, Dangman B. A re-examination of the role of oxygen in retrolental fibroplasia.  Pediatrics. 1984;  73 82-96
• 3 Liao S L, Lai S H, Kuo C Y. Effect of carbon dioxide tension in the first three days of life on the development of retinopathy of prematurity.  Chang Gung Med J. 2000;  23 755-760
• 4 Dani C, Reali M F, Bertini G, Martelli E, Pezzati M, Rubaltelli F F. The role of blood transfusions and iron intake on retinopathy of prematurity.  Early Hum Dev. 2001;  62 57-63
• 5 O'Keefe M, Kafil-Hussain N, Flitcroft I, Lanigan B. Ocular significance of intraventricular hemorrhage in premature infants.  Br J Ophthalmol. 2001;  85 357-359
• 6 Brooks S E, Marcus D M, Gillis D, Pirie E, Johnson C S, Bhatia J. The effect of blood transfusion protocol on retinopathy of prematurity: a prospective, randomized study.  Pediatrics. 1999;  104 514-518
• 7 Holmstrom G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity-a population-based study.  Acta Ophthalmol Scand. 1998;  76 204-207
• 8 The Committee for the Classification of Retinopathy of Prematurity . An international classification of retinopathy of prematurity.  Arch Ophthalmol. 1984;  102 1130-1134
• 9 Teng R J, Wu T J, Yau K I. Retinopathy of prematurity in very-low-birthweight neonates: epidemiology and risk factors.  Acta Paed Sin. 1997;  38 370-374
• 10 Chou Y H, Teng R J, Yau K I, Yang C M. Retinopathy of prematurity: an analysis of risk factors.  J Formos Med Assoc. 1993;  92 440-445
• 11 Mathew M R K, Fern A L, Hill R. Retinopathy of prematurity: are we screening too many babies?.  Eye. 2002;  16 538-542
• 12 Larsson E, Holmstrom G. Screening for retinopathy of prematurity: evaluation and modification of guidelines.  Br J Ophthalmol. 2002;  86 1399-1402
• 13 The Italian ROP Study Group . Italian multicentre study on retinopathy of prematurity.  Eur J Pediatr. 1997;  156 939-943
• 14 Lee S. Retinopathy of prematurity in the 1990s.  Neonatal Netw. 1999;  18 31-38
• 15 Hardy P, Dumont I, Bhattacharya M et al.. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy.  Cardiovasc Res. 2000;  47 489-509
• 16 Schaffer D B, Palmer E A, Plotsky D F et al.. Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group.  Ophthalmology. 1993;  100 230-237
• 17 Gallo J E, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity.  Acta Paediatr. 1993;  82 829-834
• 18 Charles J B, Ganthier R, Appiah A P. Incidence and characteristics of retinopathy of prematurity in a low-income inner-city population.  Ophthalmology. 1991;  98 14-17
• 19 Gunn T R, Easdown J, Outerbridge E W, Aranda J V. Risk factors in retrolental fibroplasias.  Pediatrics. 1980;  65 1096-1100
• 20 Purohit D M, Ellison R C, Zierler S, Miettinen O S, Nadas A S. Risk factors for retrolental fibroplasias: experience with 3,025 premature infants. National collaborative study on patent ductus arteriosus in premature infants.  Pediatrics. 1985;  76 339-344
• 21 Brown D R, Biglan A W, Stretavsky M M. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia.  J Pediatr Ophthalmol Strabismus. 1990;  27 268-271
• 22 Procianoy R S, Garcia-Prats J A, Hittner H M, Adams J M, Rudolph A J. An association between retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants.  Acta Paediatr Scand. 1981;  70 473-477
• 23 Brown D R, Milley J R, Ripepi U J, Biglan A W. Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates.  Am J Dis Child. 1987;  141 154-160
• 24 Whitelaw A. Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions.  Semin Neonatol. 2001;  6 135-146
• 25 Kelly F J. Free radical disorders of preterm infants.  Br Med Bull. 1993;  49 668-678
• 26 Termote J, Schalij-Delfos N E, Brouwers H A, Donders A R, Cats B P. New developments in neonatology: less severe retinopathy of prematurity?.  J Pediatr Ophthalmol Strabismus. 2000;  37 142-148
• 27 Kretzer F L, Hittner H M. Retinopathy of prematurity: clinical implications of retinal development.  Arch Dis Child. 1988;  63 1151-1167
• 28 Johnson L, Quinn G E, Abbasi S et al.. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.  J Pediatr. 1989;  114 827-838
• 29 Penn J S, Rajaratnam V S, Collier R J, Clark A F. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.  Invest Ophthalmol Vis Sci. 2001;  42 283-290
• 30 Danis R P, Bingaman D P, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.  Ophthalmology. 1996;  103 2099-2104
• 31 Rotschild T, Nandgaonkar B N, Yu K, Higgins R D. Dexamethasone reduces oxygen induced retinopathy in a mouse model.  Pediatr Res. 1999;  46 94-100
• 32 Ramanathan R, Siassi B, deLemos R A. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.  J Perinatol. 1995;  15 178-182
• 33 Haroon Parupia M F, Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.  J Perinatol. 2001;  21 242-247
• 34 Termote J, Schalij-Delfos N E, Donders A R, Cats B P. Do postnatal glucocorticoids and retinopathy of prematurity relate?.  Am J Perinatol. 2000;  17 291-298
• 35 Halliday H L, Ehrenkranz R A, Doyle L W. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Available at: http://156.40.88.3/cochrane/hallida3/halliday.htm
• 36 Halliday H L, Ehrenkranz R A, Doyle L W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Available at: http://156.40.88.3/cochrane/hallida2/halliday.htm
• 37 Halliday H L, Ehrenkranz R A, Doyle L W. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Available at: http://156.40.88.3/cochrane/hallida4/halliday.htm
• 38 Mizoguchi M B, Chu T G, Murphy F M, Willits N, Morse L S. Dopamine use is an indicator for the development of threshold retinopathy of prematurity.  Br J Ophthalmol. 1999;  83 425-428